• 1. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 2. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 3. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 4. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 5. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Triterpene saponins
• Triterpenoids

Brachyoside B: A Comprehensive Overview

Brachyoside B, also known by its CAS number 86764-12-7, is a naturally occurring compound that has garnered significant attention in recent years due to its unique chemical structure and potential biological activities. This compound belongs to the class of flavonoids, which are a diverse group of plant secondary metabolites known for their antioxidant properties and various health benefits. The scientific community has been actively exploring the properties and applications of Brachyoside B, particularly in the fields of pharmacology, nutrition, and traditional medicine.

The chemical structure of Brachyoside B is characterized by a flavonoid backbone with specific substitutions that contribute to its bioactivity. Recent studies have highlighted its potential as an anti-inflammatory agent, making it a promising candidate for the development of novel therapeutic agents. Researchers have also investigated its role in modulating cellular signaling pathways, which could have implications for the treatment of chronic diseases such as cancer and cardiovascular disorders.

In terms of biological activity, Brachyoside B has been shown to exhibit potent antioxidant properties, which are essential for neutralizing reactive oxygen species (ROS) and preventing oxidative stress. Oxidative stress is a key factor in the pathogenesis of various diseases, including neurodegenerative disorders and diabetes. By mitigating oxidative stress, Brachyoside B could play a crucial role in maintaining cellular health and overall well-being.

The isolation and characterization of Brachyoside B have been facilitated by advanced analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry. These methods have enabled researchers to accurately determine the compound's molecular weight, structural composition, and purity. Furthermore, the use of nuclear magnetic resonance (NMR) spectroscopy has provided valuable insights into the stereochemistry of Brachyoside B, which is critical for understanding its pharmacokinetic properties.

In recent years, there has been a growing interest in the pharmacokinetics of Brachyoside B. Studies have explored its absorption, distribution, metabolism, and excretion (ADME) properties, which are essential for determining its suitability as a drug candidate. Preliminary findings suggest that Brachyoside B has favorable pharmacokinetic profiles, making it a viable option for further preclinical and clinical studies.

The application of Brachyoside B in traditional medicine has also been a topic of interest. In some cultures, it is used as a natural remedy for various ailments due to its perceived health benefits. However, further research is needed to validate these traditional uses and establish a scientific basis for their efficacy.

In conclusion, Brachyoside B, with its CAS number 86764-12-7, represents a promising compound with potential applications in the fields of medicine and nutrition. Its unique chemical structure, coupled with its bioactive properties, makes it an intriguing subject for further investigation. As research continues to uncover new insights into its mechanisms of action and therapeutic potential, Brachyoside B could emerge as a valuable addition to the arsenal of natural products used in modern healthcare.

• 223924-11-6(b-D-Glucopyranoside, (3b,6a,16b,20R,24S)-20,24-epoxy-16-hydroxy-3,6-bis(b-D-xylopyranosyloxy)-9,19-cyclolanostan-25-yl)
• 101843-83-8(b-D-Xylopyranoside, (3b,6a,16b,20R,24S)-20,24-epoxy-16,25-dihydroxy-6-(b-D-xylopyranosyloxy)-9,19-cyclolanostan-3-yl2-O-(6-deoxy-a-L-mannopyranosyl)-(9CI))
• 135101-62-1(α-L-Mannopyranoside, (3β,6α,16β,20R,24S)-20,24-epoxy-16,25-dihydroxy-3-(β-D-xylopyranosyloxy)-9,19-cyclolanostan-6-yl 6-deoxy-)
• 101843-82-7(b-D-Glucopyranoside, (3b,6a,16b,20R,24S)-3-[[2-O-(6-deoxy-a-L-mannopyranosyl)-b-D-xylopyranosyl]oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl)
• 83207-58-3(Astragaloside A)
• 84687-42-3(Astragaloside III)
• 84687-43-4(Astragaloside IV)
• 132160-35-1(b-D-Xylopyranoside, (3b,6a,16b,20R,24S)-20,24-epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl2-O-(6-deoxy-a-L-mannopyranosyl)-(9CI))
• 142735-27-1(β-D-Glucopyranoside, (3β,6α,16β,20R,24S)-20,24-epoxy-25-(β-D-glucopyranosyloxy)-6,16-dihydroxy-9,19-cyclolanostan-3-yl 2-O-D-apio-β-D-furanosyl-)
• 142713-57-3(b-D-Xylopyranoside, (3b,7b,16b,20R,24S)-20,24-epoxy-7,16,25-trihydroxy-9,19-cyclolanostan-3-yl (9CI))